Novo Nordisk– tag –
-
Verseon Champions Physics-Based Molecular Design to Transcend AI’s Training Data in Drug Discovery
Endpoints News USA Overview Verseon asserts that physics-based molecular design can reach chemical spaces beyond the limitations of traditional screening and generative AI training data, opening untapped drug discovery realms. Their Deep... -
Large Models Reshape Chemistry: Generative AI Drives Novel Molecular Design in Drug Discovery
Google Cloud Vertex AI Search USA Overview Generative AI is fundamentally transforming drug chemistry by creating novel molecular structures rather than merely screening existing ones. These large machine learning models learn patterns o... -
Generative AI Accelerates Drug Discovery: Reshaping Molecular Design and Translational Decision-Making
Google Cloud Vertex AI Search USA Overview Generative AI is poised to revolutionize the entire drug discovery pipeline, from initial molecular design and chemical space exploration to ADMET prediction and crucial translational decision-m... -
AI Transforms Drug Discovery: Generative AI Accelerates Molecule Design to Clinical Prediction, Reducing R&D Costs and Risks
World Pharma Today Unknown Overview AI, particularly generative AI, is fundamentally transforming drug discovery in 2026 by accelerating target identification, molecule design, and outcome prediction. AI-driven platforms computationally ... -
ChemRxiv Unveils AI Workflow for Structure-Aware Small-Molecule Drug Design: Integrating Agentic, Explainable, and Generative AI for Design to Prioritization
ChemRxiv Unknown Overview A preprint on ChemRxiv describes an innovative AI workflow for structure-aware small-molecule drug design, integrating agentic and explainable machine learning with generative molecular design. This system autom... -
Shantha Biologics Secures Fill-Finish Manufacturing Agreement with Novo Nordisk for Cartridge Injectables in India
European Pharmaceutical Review India Overview Shantha Biologics has signed an agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India. This collaboration strengthens Shantha's role in supporting pharm... -
Novo Nordisk Partners with India’s Shantha Biologics for Global Cartridge Fill-Finish Services
The SouthFirst India Overview Novo Nordisk has signed an outsourcing agreement with Hyderabad-based Shantha Biologics for cartridge fill-finish manufacturing services for its global supply chain. This strategic collaboration signifies Sh... -
2026 GLP-1 Agonist Pipeline Highlights Oral Orforglipron Approval and Retatrutide’s >28% Weight Reduction
Drug Discovery News USA Overview The 2026 GLP-1 agonist clinical pipeline is focusing on enhanced weight loss efficacy through novel mechanisms. Notably, Eli Lilly's oral small-molecule GLP-1 receptor agonist, orforglipron, received FDA ... -
Ohio State University Establishes “Buckeye BioLaunch,” an AI-Powered Center for Therapeutic Discovery, Development, and Commercialization
The Ohio State University USA Overview The Ohio State University announced the establishment of "Buckeye BioLaunch," a new center leveraging artificial intelligence (AI) to accelerate therapeutic discovery, development, and commercializa... -
AI Accelerates Early Drug Discovery, But Patient Outcomes Remain the Ultimate Validation
MedCity News USA Overview Artificial intelligence is proving highly effective in accelerating early-stage drug discovery, with AI-designed candidates showing promising success rates in Phase 1 clinical trials. However, the ultimate value...
